While tumor growth and tumor angiogenesis was strikingly impaired by Vegfr2 heterozygosity, simultaneous inactivation of endothelial Fgfr1/2 did not enhance the tumor inhibitory effects, despite studies showing additive efficacy using pharmacological small molecular inhibitors targeting multiple tyrosine kinases5,25. Here, KDR is linked to neoplasm.